Principal Financial Group Inc. Lowers Stake in Semler Scientific Inc. (NASDAQ:SMLR)

Principal Financial Group Inc. decreased its holdings in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 49.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 57,385 shares of the company's stock after selling 55,102 shares during the quarter. Principal Financial Group Inc. owned 0.60% of Semler Scientific worth $2,077,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the company. BNP Paribas Financial Markets acquired a new position in shares of Semler Scientific in the 4th quarter valued at $30,000. NewEdge Advisors LLC increased its holdings in shares of Semler Scientific by 318.3% in the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock valued at $40,000 after acquiring an additional 557 shares during the period. Legal & General Group Plc increased its stake in Semler Scientific by 65.4% in the 4th quarter. Legal & General Group Plc now owns 2,056 shares of the company's stock valued at $111,000 after buying an additional 813 shares during the period. MetLife Investment Management LLC acquired a new position in Semler Scientific in the 4th quarter valued at $163,000. Finally, Cambridge Investment Research Advisors Inc. increased its stake in Semler Scientific by 10.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 6,226 shares of the company's stock valued at $225,000 after buying an additional 576 shares during the period. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Stock Performance

NASDAQ:SMLR traded up $0.52 on Tuesday, hitting $40.19. The company's stock had a trading volume of 716,767 shares, compared to its average volume of 582,469. Semler Scientific Inc. has a one year low of $21.77 and a one year high of $81.56. The stock has a fifty day moving average of $38.54 and a two-hundred day moving average of $41.05. The company has a current ratio of 0.52, a quick ratio of 0.51 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $554.14 million, a P/E ratio of -15.40 and a beta of 1.39.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The company had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.

Wall Street Analysts Forecast Growth

SMLR has been the topic of a number of recent research reports. Maxim Group upgraded shares of Semler Scientific to a "strong-buy" rating and set a $95.00 target price on the stock in a report on Wednesday, July 9th. Wall Street Zen lowered shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, Benchmark began coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They set a "buy" rating and a $101.00 price objective on the stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.